ContractClinical Trial Agreement • October 13th, 2022
Contract Type FiledOctober 13th, 2022AMENDMENT NO. 1 TO THE CLINICAL TRIAL AGREEMENT DODATEK Č. 1 KE SMLOUVĚ O PROVEDENÍ KLINICKÉHOHODNOCENÍ This Amendment No. 1 (“Amendment No. 1”) to that certain Clinical Trial Agreement dated 28th of April, 2021 (“Agreement”) by and among Fakultní nemocnice u sv. Anny v Brně located at Pekařská 53, 656 91 Brno, Czech Republic, IČ (Company ID): 00159816, DIČ (VAT ID): CZ00159816, represented by Ing. Vlastimil Vajdák, director (the “Institution”), Exelixis, Inc., located at 1851 Harbor Bay Parkway, Alameda, CA 94502, U.S.A. (the “Sponsor”), and xxxx with a place of permanent residence: xxxx date of birth: xxxx, who serves as the principal investigator (“Investigator”), each of which are also referred to herein individually as a “Party,” and collectively as the “Parties”, is effective on the day of its publishing in the Register of Contracts in accordance with the Act no. 340/2015 Coll. On the Register of Contracts (“Amendment No. 1 Effective Date”). Tento Dodatek č. 1 (dále jen „Dodatek